MR-107A-02

· Viatris Specialty LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MR-107A-02, covering 2023-08-07 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy [Phase 3]